Gary Harris with an and one vs the Miami Heat
Gary Harris (Denver Nuggets) with an and one vs the Miami Heat, 01/27/2021
If you've been living in sweatsuits for the past few months, with these shorts, that doesn't have to change.
Stocks turned negative after the Labor Department's February jobs report handily exceeded expectations, reaffirming the building momentum in the economic recovery, but also stoking a rise in Treasury yields and concerns over an economic overheating.
President Biden participates in a roundtable on the American Rescue Plan.
Twitter reacts to "WandaVision" finally exposing one character.
The Good Girls are (finally!) back this Sunday, and while they’re still breaking all sorts of bad, the hurdles that stand before them are lining up like never before. When we last left the ladies, Beth and Dean (played by Christina Hendricks and Matthew Lillard) were prepping the launch of Boland Bubbles, a hot tub […]
Riley Keough is set as a lead opposite Chris Pratt and Constance Wu in Amazon’s conspiracy-thriller series The Terminal List, based on Jack Carr’s bestselling novel. Taylor Kitsch and Jeanne Tripplehorn also star in the series, which Pratt executive produces along with Antoine Fuqua, who directs, and writer David DiGilio. The Terminal List is a […]
MIAMI BEACH, Fla., March 05, 2021 (GLOBE NEWSWIRE) -- Thomas J. Herzfeld Advisors, Inc., an SEC-registered investment adviser, and The Herzfeld Caribbean Basin Fund, Inc. (Nasdaq: CUBA) (the “Fund”) today announced the final results of the Fund’s offer to purchase up to 5% of outstanding shares of the Fund at 97.5% of NAV as of the close of ordinary trading on the NASDAQ Capital Market (the “NASDAQ”) on March 4, 2021, the expiration date. Based on the final count by American Stock Transfer & Trust Co., LLC (“AST”), the depositary for the tender offer, a total of 2,460,234.322 common shares of the Fund were validly tendered and not withdrawn. The total amount of shares tendered exceeded the offer amount, and the Fund will purchase tendered shares on a pro rata basis. Subject to final delivery of all tendered shares, the proration factor for shares purchased pursuant to the offer is 12.4656%. In accordance with the terms and conditions of the tender offer, the Fund has accepted for payment all 306,683 common shares subject to the tender offer. The purchase price per share is determined to be $6.7958. Payment for the shares accepted for purchase under the tender offer and return of all other shares tendered and not purchased will occur promptly. AST Fund Solutions, LLC is the information agent for the Offer. Shareholders with questions may call AST Fund Solutions, LLC at (866) 406-2285. About Thomas J. Herzfeld Advisors, Inc. Thomas J. Herzfeld Advisors, Inc., founded in 1984, is an SEC registered investment advisor, specializing in investment analysis and account management in closed-end funds. The Firm also specializes in investment in the Caribbean Basin. The HERZFELD/CUBA division of Thomas J. Herzfeld Advisors, Inc. serves as the investment advisor to The Herzfeld Caribbean Basin Fund, Inc. a publicly traded closed-end fund (NASDAQ: CUBA). More information about the advisor can be found at www.herzfeld.com. Past performance is no guarantee of future performance. An investment in the Fund is subject to certain risks, including market risk. In general, shares of closed-end funds often trade at a discount from their net asset value and at the time of sale may be trading on the exchange at a price which is more or less than the original purchase price or the net asset value. There can be no assurance that any Share repurchases will reduce or eliminate the discount of the Fund’s market price to the Fund’s net asset value per share. An investor should carefully consider the Fund’s investment objective, risks, charges and expenses. Please read the Fund’s disclosure documents before investing.
CAMBRIDGE, Mass., March 05, 2021 (GLOBE NEWSWIRE) -- Vor Biopharma (Nasdaq: VOR), a cell therapy company pioneering engineered hematopoietic stem cell (eHSC) therapies combined with targeted therapies for the treatment of cancer, today announced that the Company will be participating in the Barclays Global Healthcare Conference, which will take place virtually on March 9-11, 2021. Robert Ang, MBBS, MBA, Vor’s President and Chief Executive Officer, and Nathan Jorgensen, PhD, Chief Financial Officer, are scheduled to present on Thursday, March 11, 2021, at 3:00 p.m. E.T. A live webcast of the presentation can be accessed via the Investors section of the Company's website at www.vorbio.com. An archived replay of the webcast will be available on the Company's website following the conference. About Vor Biopharma Vor Biopharma is a cell therapy company that aims to transform the lives of cancer patients by pioneering engineered hematopoietic stem cell (eHSC) therapies to create next-generation, treatment-resistant transplants that unlock the potential of targeted therapies. By removing biologically redundant proteins from eHSCs, we design these cells and their progeny to be treatment-resistant to complementary targeted therapies, thereby enabling these therapies to selectively destroy cancerous cells while sparing healthy cells. Contacts: Investor: Constantine Davides, CFAWestwicke +1 339-970-2846 constantine.davides@westwicke.com Media: Mary Carmichael Ten Bridge Communications +1 617-413-3543 mary@tenbridgecommunications.com
Boussard & Gavaudan Holding Limiteda closed-ended investment company incorporated with limited liability under the laws of Guernsey with registration number 45582 Legal Entity Identifier: 5493002XNM3W9D6DF327 APPOINTMENT OF DIRECTOR The Board of the Company is pleased to announce the appointment of Mr Bruce James as a non-executive director of the Company. Mr James is the Managing Director of Montrose Asset Management Limited, a Guernsey based company specializing in investment management. He is a graduate of the University of Cape Town and a UK qualified solicitor. He is a Chartered Member of the Institute for Securities and Investments and a member of STEP. Bruce also holds the IoD Certificate in Company Direction and is a member of the Institute of Directors. Mr James holds a range of non-executive directorships on fund management and fund investment companies. As at the date of this announcement, he holds or held, within the previous five years, the following directorship in other publicly quoted companies: CurrentPast Cayzer Continuation PCC Limited Mr James and persons closely associated with him are not beneficially interested in any Ordinary Shares of no par value shares in the Fund. Andrew Henton, Chairman of the Company, said: “We are delighted to welcome Mr James to the Company. We have no doubt that his extensive experience and sector knowledge within the investment company arena will be of considerable support to the Fund as we continue to focus on providing stable income and capital growth to our shareholders. We look forward to Bruce’s future contribution to the Fund.” There is no information concerning Mr James which is required to be disclosed pursuant to Listing Rule 9.6.13 R (2) to (6) inclusive and the Board consider him to be independent on appointment per the AIC Code of Corporate Governance. 5 March 2021 END For further information, please contact: Boussard & Gavaudan Investment Management LLP +44 20 3751 5400Emmanuel Gavaudan (London) +44 203 751 5389Francois Xavier Baud (London) +44 203 751 5395 www.bgholdingltd.com The Company is established as a closed-ended investment company domiciled in Guernsey. The Company has been authorised by the Guernsey Financial Services Commission as an authorised closed-ended investment scheme. The Company is registered with the Dutch Authority for the Financial Markets as a collective investment scheme pursuant to article 2:73 in conjunction with 2:66 of the Dutch Financial Supervision Act (Wet op het financieel toezicht). The shares of the Company (the "Shares") are listed on Euronext Amsterdam. The Shares are also listed on the Official List of the UK Listing Authority and admitted to trading on the London Stock Exchange plc's main market for listed securities. This is not an offer to sell or a solicitation of any offer to buy any securities in the United States or in any other jurisdiction. This announcement is not intended to and does not constitute, or form part of, any offer or invitation to purchase any securities or the solicitation of any vote or approval in any jurisdiction, nor shall there be any sale, issuance or transfer of the securities referred to in this announcement in any jurisdiction in contravention of applicable law. Neither the Company nor BG Fund Plc has been, and neither will be, registered under the US Investment Company Act of 1940, as amended (the "Investment Company Act"). In addition the securities referenced in this announcement have not been and will not be registered under the US Securities Act of 1933, as amended (the "Securities Act"). Consequently any such securities may not be offered, sold or otherwise transferred within the United States or to, or for the account or benefit of, US persons except in accordance with the Securities Act or an exemption therefrom and under circumstances which will not require the issuer of such securities to register under the Investment Company Act. No public offering of any securities will be made in the United States. You should always bear in mind that: all investment is subject to risk; results in the past are no guarantee of future results; the investment performance of BGHL may go down as well as up. You may not get back all of your original investment; and if you are in any doubt about the contents of this communication or if you consider making an investment decision, you are advised to seek expert financial advice. This communication is for information purposes only and the information contained in this communication should not be relied upon as a substitute for financial or other professional advice. END OF ANNOUNCEMENT Attachment 2020 03 05 - BGHL - Appointment of Bruce James (non-executive director) - v2
Boussard & Gavaudan Holding Limiteda closed-ended investment company incorporated with limited liability under the laws of Guernsey with registration number 45582 Legal Entity Identifier: 5493002XNM3W9D6DF327 APPOINTMENT OF DIRECTOR The Board of the Company is pleased to announce the appointment of Mr Bruce James as a non-executive director of the Company. Mr James is the Managing Director of Montrose Asset Management Limited, a Guernsey based company specializing in investment management. He is a graduate of the University of Cape Town and a UK qualified solicitor. He is a Chartered Member of the Institute for Securities and Investments and a member of STEP. Bruce also holds the IoD Certificate in Company Direction and is a member of the Institute of Directors. Mr James holds a range of non-executive directorships on fund management and fund investment companies. As at the date of this announcement, he holds or held, within the previous five years, the following directorship in other publicly quoted companies: CurrentPast Cayzer Continuation PCC Limited Mr James and persons closely associated with him are not beneficially interested in any Ordinary Shares of no par value shares in the Fund. Andrew Henton, Chairman of the Company, said: “We are delighted to welcome Mr James to the Company. We have no doubt that his extensive experience and sector knowledge within the investment company arena will be of considerable support to the Fund as we continue to focus on providing stable income and capital growth to our shareholders. We look forward to Bruce’s future contribution to the Fund.” There is no information concerning Mr James which is required to be disclosed pursuant to Listing Rule 9.6.13 R (2) to (6) inclusive and the Board consider him to be independent on appointment per the AIC Code of Corporate Governance. 5 March 2021 END For further information, please contact: Boussard & Gavaudan Investment Management LLP +44 20 3751 5400Emmanuel Gavaudan (London) +44 203 751 5389Francois Xavier Baud (London) +44 203 751 5395 www.bgholdingltd.com The Company is established as a closed-ended investment company domiciled in Guernsey. The Company has been authorised by the Guernsey Financial Services Commission as an authorised closed-ended investment scheme. The Company is registered with the Dutch Authority for the Financial Markets as a collective investment scheme pursuant to article 2:73 in conjunction with 2:66 of the Dutch Financial Supervision Act (Wet op het financieel toezicht). The shares of the Company (the "Shares") are listed on Euronext Amsterdam. The Shares are also listed on the Official List of the UK Listing Authority and admitted to trading on the London Stock Exchange plc's main market for listed securities. This is not an offer to sell or a solicitation of any offer to buy any securities in the United States or in any other jurisdiction. This announcement is not intended to and does not constitute, or form part of, any offer or invitation to purchase any securities or the solicitation of any vote or approval in any jurisdiction, nor shall there be any sale, issuance or transfer of the securities referred to in this announcement in any jurisdiction in contravention of applicable law. Neither the Company nor BG Fund Plc has been, and neither will be, registered under the US Investment Company Act of 1940, as amended (the "Investment Company Act"). In addition the securities referenced in this announcement have not been and will not be registered under the US Securities Act of 1933, as amended (the "Securities Act"). Consequently any such securities may not be offered, sold or otherwise transferred within the United States or to, or for the account or benefit of, US persons except in accordance with the Securities Act or an exemption therefrom and under circumstances which will not require the issuer of such securities to register under the Investment Company Act. No public offering of any securities will be made in the United States. You should always bear in mind that: all investment is subject to risk; results in the past are no guarantee of future results; the investment performance of BGHL may go down as well as up. You may not get back all of your original investment; and if you are in any doubt about the contents of this communication or if you consider making an investment decision, you are advised to seek expert financial advice. This communication is for information purposes only and the information contained in this communication should not be relied upon as a substitute for financial or other professional advice. END OF ANNOUNCEMENT Attachment 2020 03 05 - BGHL - Appointment of Bruce James (non-executive director) - v2
Police spokesman Sadiq Ali Adan blamed the attack on the local al-Shabab extremist group, which is linked to al-Qaida and often targets Mogadishu with bombings. Security in Mogadishu had been especially heavy, with thousands of government forces deployed in anticipation of a planned demonstration on Saturday by an alliance of opposition leaders over the country's delayed national election.
CONMEBOL said on Friday that FIFA was “looking for a solution to the stalemate” as Manchester City's Pep Guardiola became the latest manager to reveal he won't let his players travel to international matches this month if they have to quarantine on their return. “They are not going to fly, for sure,” Guardiola said.
NEW YORK — The following is a list of initial public offerings planned for the coming week. Sources include IPO ETF manager Renaissance Capital, and SEC filings. Week of March 8 Coupang - Seoul, South Korea, 120 million shares, priced $27-$30, managed by Goldman Sachs/Allen & Company. Proposed NYSE CPNG. Business: Korea e-commerce site. First High-School Education Group - Kunming, China, 7.5 million shares, priced $9.50-$10.50, managed by The Benchmark Company/AMTD Global Markets. Proposed NYSE symbol FHS. Business: Operates private high schools and provides tutoring services in China. Hayward Holdings - Berkeley Heights, N.J., 40.3 million shares, priced $17-$19, managed by BofA Securities/Goldman Sachs. Proposed NYSE HAYW. Business: Supplier of pool equipment and systems. JOANN - Hudson, Ohio, 10.9 million shares, priced $15-$17, managed by BofA Securities/Credit Suisse. Business: Multi-channel fabric and crafts retailer with about 860 stores. Jowell Global - Shanghai, China, 3.7 million shares, priced at $7, managed by Network 1 Financial Securities. Proposed Nasdaq symbol JWEL. Business: Operates an e-commerce platform for cosmetics and health products in China. Universe Pharmaceuticals - Jiangxi, China, 5 million shares, priced $5-$7, managed by Univest Securities. Proposed Nasdaq symbol UPC. Business: Chinese pharmaceutical specializing in traditional Chinese medicine derivatives. The Associated Press
The boozy drink will be available in citrus and tropical 12-can variety packs
The jobs improvement came amid falling new COVID-19 cases, quickening vaccination rates and additional pandemic relief money from the government, putting the labor market recovery back on firmer footing and on course for further gains in the months ahead. "There's momentum in the labor market and what that’s doing is providing I think more optimism that the growth picture is looking even better." A rollout of COVID-19 vaccines and impending U.S. fiscal stimulus have boosted confidence in an economic recovery, adding fuel to expectations of higher inflation.
Former Vice President Mike Pence will narrate a four-part limited series on the life of Rush Limbaugh for Fox News Media’s subscription streaming service Fox Nation. The four-part series is called the Age of Rush, and will drop on March 10. Pence is a former radio host himself, and others featured in the project include […]
The latest news on COVID-19 developments in Canada (all times eastern): 2:50 p.m. Saskatchewan is reporting 207 new cases of COVID-19. The province also says two more people have died from the illness. There are 138 people in hospital with the virus, and 22 of them are in intensive care. --- 1:50 p.m. Ontario's updated vaccination plan will see shots administered based on factors including age, neighbourhood, existing health conditions and inability to work from home. The province notes, however, that the plan doesn't factor in the newly approved Johnson & Johnson shot and additional doses of the Pfizer-BioNTech vaccine. Shots will go to seniors 75 and older starting in April with a goal of offering first shots to everyone 60 and older by the end of May. Doses will also be offered starting in April to people with specific health conditions and some caregivers, including those in congregate settings. Thirteen public health units, including Toronto, Windsor, York and Peel, will receive additional doses for hot-spot neighbourhoods between April and June. Essential workers who can't work from home will be offered doses at the end of Phase 2, while adults 59 and younger are expected to receive the shot in July, though the timeline is subject to change. --- 1:40 p.m. Manitoba is reporting 53 additional COVID-19 cases and one death. The province is also reporting one new confirmed case involving the variant first seen in South Africa. The percentage of people testing positive continues to drop, with the five-day average at three per cent. --- 1 p.m. New Brunswick is reporting four new cases of COVID-19, three of which are in the Miramichi region. Health officials say the province has 33 active reported cases and three people are in hospital with the disease, including two in intensive care. New Brunswick is announcing it will ease public health restrictions across the province as of this Sunday because COVID-19 infections are on a steady trend downward. The province's chief medical officer of health, Dr. Jennifer Russell, says the decision to shift to the lower, yellow pandemic-alert level will be revisited if there is a spike in cases over the weekend. As well, Russell is confirming that with the expected arrival of the first shipment of the two-dose Oxford-AstraZeneca vaccine later this month, the province is pledging to provide one dose of COVID-19 vaccine to every New Brunswicker before the end of June. --- 12:50 p.m. A stay-at-home order will lift next week in Toronto, Peel Region and North Bay Parry Sound. The three Ontario regions were the last ones still under the order, while most of the province transitioned back to the government's colour-coded pandemic response framework last month. Toronto and Peel will go into the strictest "grey lockdown" category of the framework, as recommended by public health officials in those regions. The province says North Bay will be placed in the red zone, the second most restrictive level of pandemic measures. --- 12:45 p.m. There is one new case of COVID-19 in Newfoundland and Labrador. The figures released today bring the total number of active cases in the province to 113. Health Minister John Haggie said he was feeling optimistic and said the province is on track for a "new summer" where residents can travel around the island. The province is inviting people who are asymptomatic to seek testing to see if there are any pockets of COVID-19 still undetected in the province. --- 12:05 p.m. Pfizer has told Canada it will speed up delivery of the shipments of its COVID-19 vaccine. Prime Minister Justin Trudeau says 1.5 million additional doses are coming in March. He says another one million doses will come ahead of schedule in both April and May. Trudeau says that means there will be eight million doses of the Pfzier-BioNTech vaccine in Canada by the end of this month. --- 11:55 a.m. Nunavut is reporting four new cases of COVID-19 today for a total of 17. All the new cases are in Arviat, the only community in Nunavut with active cases of COVID-19. Despite the rise in cases, chief public health officer Dr. Michael Patterson says the outbreak in Arviat is contained. Arviat has been under a strict lock down for 112 days, with all school and non-essential businesses closed and travel restricted. --- 11:45 a.m. Nunavut's health minister says the territory is on track to receive 38,000 doses of the Moderna vaccine by mid-March, enough to vaccinate 75 per cent of the eligible population. Lorne Kusugak says there will be at least one vaccination clinic in all of Nunavut's 25 communities by the end of March. Kusugak also announced a mass vaccination clinic will launch in Iqaluit on March 15. Starting March 10, residents ages 18 years and up can call Iqaluit Public health to book an appointment. --- 11:10 a.m. Quebec is reporting 798 new cases of COVID-19 today and 10 more deaths linked to the virus. Health officials say hospitalizations dropped by nine, to 617, and that 111 people were in intensive care, a drop of four. The province says it administered more than 18,000 doses of vaccine, for at total of 510,479. --- 10:40 a.m. Ontario is reporting 1,250 new cases of COVID-19 in the province. Health Minister Christine Elliott says that 337 of those new cases are in Toronto, 167 are in Peel Region, and 129 are in York Region. The province also reports a single-day high of 35,886 doses of COVID-19 vaccine administered since Thursday's update. Ontario also reports 22 more deaths linked to the virus. --- 10:35 a.m. Nova Scotia is reporting two new cases of COVID-19 today. Health officials say the new cases are in the health region that includes Halifax. They say one case involves a close contact of a previously reported infection and the other is under investigation. The province has 31 active reported cases of the disease. --- 10:20 a.m. The Manitoba government is now predicting it will be able to provide all eligible adults with a first dose of COVID-19 vaccines by the end of June. Officials say it might even be as early as mid-May, depending on the flow of supplies. The timeline has been moved up by months as more vaccines have been approved by the federal government. --- 10 a.m. Health Canada has approved the COVID-19 vaccine from Johnson and Johnson, saying it has the evidence showing the vaccine is both safe and effective against the novel coronavirus that causes the disease. It is the fourth vaccine to be approved in Canada and the first and only one Canada has purchased that requires just a single dose. Canada has pre-purchased 10 million doses, with options to buy another 28 million. --- This report by The Canadian Press was first published March 5, 2021. The Canadian Press
MAYFIELD VILLAGE, OHIO, March 05, 2021 (GLOBE NEWSWIRE) -- The Board of Directors of The Progressive Corporation (NYSE:PGR) today declared a $0.10 per common share dividend, payable April 15, 2021, to shareholders of record at the close of business on April 7, 2021 (ex-dividend date of April 6, 2021). About ProgressiveThe Progressive Group of Insurance Companies makes it easy to understand, buy and use auto insurance. Progressive offers choices so consumers can reach us whenever, wherever and however it’s most convenient - online at progressive.com, by phone at 1-800-PROGRESSIVE, on a mobile device or in-person with a local agent. Progressive provides insurance for personal and commercial autos and trucks, motorcycles, boats, recreational vehicles, and homes; it is the third largest auto insurer in the country, a leading seller of motorcycle and commercial auto insurance, and one of the top 15 homeowners insurance carriers. Founded in 1937, Progressive continues its long history of offering shopping tools and services that save customers time and money, like Name Your Price®, Snapshot®, and HomeQuote Explorer®. The Common Shares of The Progressive Corporation, the Mayfield Village, Ohio-based holding company, trade publicly at NYSE:PGR. Company Contact:Douglas S. Constantine(440) 910-3563The Progressive Corporation6300 Wilson Mills RoadMayfield Village, Ohio 44143http://www.progressive.com
A British judge ruled Friday that an apology must appear in the Mail on Sunday and on the home page of the MailOnline website
Texas regulators say they will not lower skyrocketing prices from the winter storm: “It’s nearly impossible to unscramble this sort of egg.”